(Q35824087)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15229516%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15229516%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15229516%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Wolfgang Löscher

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15229516%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15229516%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15229516%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15229516%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15229516%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

685-692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15229516%20AND%20SRC:MED&resulttype=core&format=json

New horizons in the development of antiepileptic drugs

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Shared mechanisms and comorbidities in neurologic and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Comorbidity of migraine and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

The neurobiology of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Gabapentin as a potential treatment for anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Treatment of social phobia with gabapentin: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Effects of gabapentin on anxiety induced by simulated public speaking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Lamotrigine in the treatment of painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Gabapentin use in neuropathic pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Newer antiepileptic drugs: possible uses in the treatment of neuropathic pain and migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Antiepileptic drugs in the management of cluster headache and trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Mechanistic Stratification of Antineuralgic Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

The changes in expression of three subtypes of TTX sensitive sodium channels in sensory neurons after spinal nerve ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Changes in expression of voltage-dependent ion channel subunits in dorsal root ganglia of rats with radicular injury and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

The tetrodotoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

beta3, a novel auxiliary subunit for the voltage-gated sodium channel, is expressed preferentially in sensory neurons and is upregulated in the chronic constriction injury model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Beta3, a novel auxiliary subunit for the voltage gated sodium channel is upregulated in sensory neurones following streptozocin induced diabetic neuropathy in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Changes in the mRNAs encoding subtypes I, II and III sodium channel alpha subunits following kainate-induced seizures in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Induction of neonatal sodium channel II and III alpha-isoform mRNAs in neurons and microglia after status epilepticus in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Molecular and functional changes in voltage-dependent Na(+) channels following pilocarpine-induced status epilepticus in rat dentate granule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Successful treatment of painful traumatic mononeuropathy with carbamazepine: insights into a possible molecular pain mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Wind-up of spinal cord neurones and pain sensation: much ado about something?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Distinct electrophysiological effects of two spinally administered membrane stabilising drugs, bupivacaine and lamotrigine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Pain perception in mice lacking the beta3 subunit of voltage-activated calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Localization of N-type Ca2+ channels in the rat spinal cord following chronic constrictive nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Dorsal root ganglion neurons show increased expression of the calcium channel alpha2delta-1 subunit following partial sciatic nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Redox modulation of T-type calcium channels in rat peripheral nociceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Reversal of experimental neuropathic pain by T-type calcium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Effects of ethosuximide, a T-type Ca(2+) channel blocker, on dorsal horn neuronal responses in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Thalamic Control of Visceral Nociception Mediated by T-Type Ca 2+ Channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Mechanical and thermal antinociception in rats following systemic administration of mibefradil, a T-type calcium channel blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Neurobiology of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Recent advances in the molecular understanding of voltage-gated Ca2+ channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Antiepileptic drugs in migraine prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Topiramate for migraine prevention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

From mutation to myotonia in sodium channel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

The spectrum of ectopic motor nerve behavior: from fasciculations to neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

The neuronal channelopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Essential tremor: differential diagnosis and current therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

A double-blind placebo-controlled trial of topiramate treatment for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Hyperekplexia in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Hyperekplexia: a treatable neurogenetic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Antiepileptic drugs in psychiatry-focus on randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Search for a common mechanism of mood stabilizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

A common mechanism of action for three mood-stabilizing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Neural and developmental actions of lithium: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Inhibition of the high affinity myo-inositol transport system: a common mechanism of action of antibipolar drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

The cellular neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Valproate and the symptomatic treatment of schizophrenia spectrum patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Antiepileptic drugs in schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

New neurochemical markers for psychosis: a working hypothesis of their operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Gabapentin versus Ropinirole in the Treatment of Idiopathic Restless Legs Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Gabapentin decreases membrane calcium currents in injured as well as in control mammalian primary afferent neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

Calcium current block by (-)-pentobarbital, phenobarbital, and CHEB but not (+)-pentobarbital in acutely isolated hippocampal CA1 neurons: comparison with effects on GABA-activated Cl- current

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Changes of sodium channel expression in experimental painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain.

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Upregulation of Sodium Channel Nav1.3 and Functional Involvement in Neuronal Hyperexcitability Associated with Central Neuropathic Pain after Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Nav1.3 sodium channels: rapid repriming and slow closed-state inactivation display quantitative differences after expression in a mammalian cell line and in spinal sensory neurons.

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions.

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Carbamazepine inhibits spontaneous activity in experimental neuromas

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats.

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Gabapentin, ineffective in normal rats, markedly reduces C-fibre evoked responses after inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Further evidence for the role of the alpha(2)delta subunit of voltage dependent calcium channels in models of neuropathic pain

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

The effect of systemic zonisamide (Zonegran) on thermal hyperalgesia and mechanical allodynia in rats with an experimental mononeuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Gabapentin for familial paroxysmal dystonic choreoathetosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

A family with an atonic variant of paroxysmal kinesigenic choreoathetosis and hypercalcitoninemia

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Paroxysmal kinesigenic dyskinesias

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Effects of phenytoin in two myotonic horses with hyperkalemic periodic paralysis

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Hereditary continuous muscle fiber activity

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Hereditary myokymia and paroxysmal ataxia linked to chromosome 12 is responsive to acetazolamide

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

The role of the extracellular signal-regulated kinase signaling pathway in mood modulation.

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

The GABAergic system in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Gabapentin as an adjunctive treatment in bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.

1 reference

https://api.crossref.org/works/10.1038%2FNM1074

7 January 2021

Identifiers

DOI

10.1038/NM1074

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15229516%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference